Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Antibiotic Resistance Market In 2029?

In recent times, the market size of antibiotic resistance has experienced significant growth. Projected growth will see an increase from $12.21 billion in 2024 to $12.85 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.3%. The growth experienced in the past can be attributed to factors such as the absence of new antibiotics, the misuse, and overuse of antimicrobials in humans, animals, and plants, heavy contamination of waste effluents, slow vaccination rates, and a lack of diagnostic tools.

In the coming years, the antibiotic resistance market is anticipated to experience a robust expansion. The market is projected to reach$16.9 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.1%. The projected growth during the forecast period can be linked to factors such as unfinished treatment regimens, globalization and travel, ineffective infection prevention and control measures, self-medication, cross-species transmission, and high population density. Noteworthy market trends during the forecast period encompass advances in drug delivery technology, increased global collaboration for surveillance, the growing influence of artificial intelligence, and an upsurge in innovative therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12131&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Antibiotic Resistance Market?

The increasing instances of drug-resistant infections are predicted to drive the growth of the antibiotic-resistance market in the future. These infections arise from bacteria that have developed resistance to drugs, making the disease they cause much more challenging to treat, if not impossible. Drugs that resist antimicrobial agents are capable of delivering more effective treatment outcomes for various drug-resistant infections, focusing on both primary and secondary pathogens. The treatment’s efficacy depends on the resistance mechanisms and microbiome community interaction structure. For example, a UK Health Security Agency report in November 2023 indicated that an estimated 58,224 individuals in England had an antibiotic-resistant infection in 2022. This marks a 4% rise from the 55,792 instances reported in 2021. Consequently, the rising frequency of drug-resistant infections is bolstering the antibiotic resistance market.

Which Primary Segments of the Antibiotic Resistance Market Are Driving Growth and Industry Transformations?

The antibiotic resistancemarket covered in this report is segmented –

1) By Drug Class: Beta Lactum Antibiotic; Cephalosporins; Quinolones Antibiotics; Macrolide Antibiotics; Tetracyclines; Oxazolidinones; Other Drug Classes

2) By Pathogen: Staphylococcus Aureus; Staphylococcus Pneumonia; Neisseria Gonorrhoeae; Enterococcus Faecium; Escherichia Coli; Klebsiella Pneumonia; Shigella; Clostridium Difficile; Other Pathogens

3) By Disease Type: Urinary Tract Infection; Intra-Abdominal Infection; Blood Stream infections; Clostridium Difficile Infections; Other Disease Types

4) By Mechanism Of Action: Protein Synthesis Inhibitors; Cell Wall Synthesis Inhibitors; RNA Synthesis Inhibitors; DNA Synthesis Inhibitors; Other Mechanism Of Actions

5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End-users

Subsegments:

1) By Beta Lactam Antibiotics: Penicillins; Cephalosporins; Carbapenems; Monobactams

2) By Cephalosporins: First-generation; Second-generation; Third-generation; Fourth-generation

3) By Quinolones Antibiotics: Fluoroquinolones; Other Quinolones

4) By Macrolide Antibiotics: Erythromycin; Azithromycin; Clarithromycin

5) By Tetracyclines: Doxycycline; Minocycline; Tetracycline

6) By Oxazolidinones: Linezolid; Tedizolid

7) By Other Drug Classes: Glycopeptides; Lipopeptides; Streptogramins; Polymyxins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12131&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Antibiotic Resistance Market?# Market?

North America was the largest region in the antibiotic resistance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Antibiotic Resistance Market?

A significant trend emerging in the antibiotic resistance market is the focus on product innovation. Businesses that dominate this market are concentrating on the creation of groundbreaking products to solidify their market stance. An example of this is Alkem Laboratories Limited, a pharmaceutical enterprise based in India, which in January 2023, unveiled Zidavi, an innovative antibiotic designed for multi-drug resistant (MDR) infections. This was undertaken to ensure the product’s accessibility, affordability, and availability, while also being focused on saving the lives of critically sick individuals. Zidavi, a distinctive blend of ceftazidime and avibactam, is effective against infections triggered by MDR gram-negative pathogens. This antibiotic is available as a sterile powdered concentrate for infusion, containing 2g of ceftazidime pentahydrate and 0.5g of avibactam sodium in each single-dose vial. It also serves as an efficient option for treating hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) originating from meropenem and colistin.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report

What Parameters Are Used to Define the Antibiotic Resistance Market?

Antimicrobial resistance is a condition that occurs when microorganisms such as bacteria and fungi gain the capacity to resist medications that are meant to kill them. Resistance to infections is challenging to treat, leading to the death of an infected individual in the worst cases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12131

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model